Topline Data from a Randomized, Double Blind, Placebo Controlled Phase 2 Study of ATH434 in Multiple System Atrophy (S37.008)
Evaluate the efficacy, biomarker response and safety of ATH434 treatment in early Multiple system atrophy (MSA)
Authors
- Cynthia S. Wong (ORCID: https://orcid.org/0000-0003-3576-1232)
- Paula Trujillo Díaz (ORCID: https://orcid.org/0009-0000-4703-5700)
- Daniel O. Claassen (ORCID: https://orcid.org/0000-0002-9853-4902)
- Margaret Bradbury
- David Stamler
- Christine Lucas
Institutions
- Vanderbilt University Medical Center (US)
Publication Details
- Journal
- Neurology
- Published
- 2025-04-07
- DOI
- https://doi.org/10.1212/wnl.0000000000212526
- Primary Topic
- Diet and metabolism studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00